Trials / Completed

CompletedNCT02913170

Nattokinase Supplementation and Hemostatic Factors

Status: Completed
Phase: Phase 4
Study type: Interventional
Enrollment: 100 (actual)

Sponsor: Yonsei University · Academic / Other
Sex: All
Age: 20 Years – 69 Years
Healthy volunteers: Not accepted

Summary

The aim of this study is to examine the effects of nattokinase supplementation on hemostatic factors in nondiabetic and hypercholesterolemic subjects. Collagen-epinephrine closure time, prothrombin time, activated partial thromboplastin time, fibrinogen levels, and lipid profiles were measured at baseline and at 8-week follow-up.

Conditions

Hypercholesterolemia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Nattokinase
DIETARY_SUPPLEMENT	Placebo

Timeline

Start date: 2015-05-01
Primary completion: 2016-09-01
Completion: 2016-09-01
First posted: 2016-09-23
Last updated: 2016-09-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02913170. Inclusion in this directory is not an endorsement.